Medibox Pharma Private Limited, a active private limited company, was established on 19 August 2016 in Delhi, Delhi, India. Engaging in online healthcare product retail within the information and communication sector, it holds CIN: U72900DL2016PTC399490. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.85 M.
It upholds a compliant status. Employing 44 professional, Its leadership includes Manju Bist (Director), Gopi Nath Sahu (Director), Arushi Jain (Director). Past directors included Randhir Mishra, Geetanjali Sharma, Bhavik Kumar. It holds ₹9.00 Cr open charges and no settled loans. Its latest AGM occurred on 27 May 2025, with the balance sheet filed on 31 March 2025. It is based at 201, Mohan Place, Lsc, C-Block, Saraswati Vihar, Delhi, Delhi, 110034.
U72900DL2016PTC399490
399490
19 August 2016
₹5.00 M
₹3.85 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medibox Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manju Bist | Director | 06 Feb 2025 | Current |
| Gopi Nath Sahu | Director | 13 Feb 2024 | Current |
| Arushi Jain | Director | 08 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Dec 2016 | Past |
| Pramod Abcsdd | Additional Director | 11 Nov 2024 | Past |
| Pramod Abcsdd | Ceo(Kmp) | - | Past |
| Pramod Abcsdd | Additional Director | 26 May 2025 | Past |
| Pramod Abcsdd | Director | 04 Sep 2020 | Past |
| Pramod Abcsdd | Nominee Director | 08 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medibox Pharma Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 8.61% increase. The company also saw a substantial improvement in profitability, with a 28.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 80.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Medibox Pharma had a promoter holding of 96.54% and a public holding of 3.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹90,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2025 | Hdfc Bank Limited | ₹2.00 Cr | Open |
| 27 Mar 2024 | The Hongkong And Shanghai Banking Corporation Limited | ₹7.00 Cr | Open |
Explore comprehensive loan charge details -
Medibox Pharma has a workforce of 44 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medibox Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medibox Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medibox Pharma Private Limited last Annual general meeting of members was held on 27 May 2025 as per latest MCA records. was completed.
Progress on Medibox Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 20.00 M with Charge ID 101072278 was registered on 11 Mar 2025. was recorded as a recent event.
The activity Manju Bist was appointed as a Director was appointed as a Director on 06 Feb 2025 & has been associated with this company since 9 months 18 days . was completed.
Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 70.00 M with Charge ID 100894203 was registered on 27 Mar 2024. was documented.
The activity Gopi Nath Sahu was appointed as a Director was appointed as a Director on 13 Feb 2024 & has been associated with this company since 1 year 9 months . was completed.
The CIN of Medibox Pharma Private Limited is U72900DL2016PTC399490.
Medibox Pharma Private Limited is headquartered at 201, Mohan Place, Lsc, C-Block, Saraswati Vihar, Delhi, Delhi, 110034.
Medibox Pharma Private Limited was incorporated on 19 August 2016.
The current directors of Medibox Pharma Private Limited are
The primary industry of Medibox Pharma Private Limited is Information And Communication.
Medibox Pharma Private Limited is unlisted.
The authorized capital of Medibox Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹3.85 M.
The compliance status of Medibox Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX